Integragen (France) Market Value

ALINT Stock  EUR 0.44  0.01  2.22%   
Integragen's market value is the price at which a share of Integragen trades on a public exchange. It measures the collective expectations of Integragen investors about its performance. Integragen is selling at 0.44 as of the 23rd of November 2024; that is 2.22% down since the beginning of the trading day. The stock's last reported lowest price was 0.44.
With this module, you can estimate the performance of a buy and hold strategy of Integragen and determine expected loss or profit from investing in Integragen over a given investment horizon. Check out Integragen Correlation, Integragen Volatility and Integragen Alpha and Beta module to complement your research on Integragen.
Symbol

Please note, there is a significant difference between Integragen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Integragen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integragen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Integragen 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integragen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integragen.
0.00
10/24/2024
No Change 0.00  0.0 
In 30 days
11/23/2024
0.00
If you would invest  0.00  in Integragen on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Integragen or generate 0.0% return on investment in Integragen over 30 days. Integragen is related to or competes with Biomerieux, Eurofins Scientific, Sartorius Stedim, and SEB SA. IntegraGen SA provides human genome analysis services for academic and private laboratories in France and the United Sta... More

Integragen Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integragen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integragen upside and downside potential and time the market with a certain degree of confidence.

Integragen Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Integragen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integragen's standard deviation. In reality, there are many statistical measures that can use Integragen historical prices to predict the future Integragen's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integragen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.445.56
Details
Intrinsic
Valuation
LowRealHigh
0.020.405.52
Details
Naive
Forecast
LowNextHigh
0.010.435.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.440.500.56
Details

Integragen Backtested Returns

Integragen holds Efficiency (Sharpe) Ratio of -0.0786, which attests that the entity had a -0.0786% return per unit of risk over the last 3 months. Integragen exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Integragen's Standard Deviation of 5.08, risk adjusted performance of (0.05), and Market Risk Adjusted Performance of (2.27) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.16, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Integragen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Integragen is expected to be smaller as well. At this point, Integragen has a negative expected return of -0.4%. Please make sure to check out Integragen's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Integragen performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.26  

Poor predictability

Integragen has poor predictability. Overlapping area represents the amount of predictability between Integragen time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integragen price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Integragen price fluctuation can be explain by its past prices.
Correlation Coefficient0.26
Spearman Rank Test-0.02
Residual Average0.0
Price Variance0.0

Integragen lagged returns against current returns

Autocorrelation, which is Integragen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Integragen's stock expected returns. We can calculate the autocorrelation of Integragen returns to help us make a trade decision. For example, suppose you find that Integragen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Integragen regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Integragen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Integragen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Integragen stock over time.
   Current vs Lagged Prices   
       Timeline  

Integragen Lagged Returns

When evaluating Integragen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Integragen stock have on its future price. Integragen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Integragen autocorrelation shows the relationship between Integragen stock current value and its past values and can show if there is a momentum factor associated with investing in Integragen.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Integragen Stock Analysis

When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.